-+ 0.00%
-+ 0.00%
-+ 0.00%
XORTX THERAPEUTICS shares rose 23% to break through $2 in after-hours trading after the company updated the progress of a clinical trial application for gout treatment submitted to Health Canada.
Share
Listen to the news
XORTX THERAPEUTICS shares rose 23% to break through $2 in after-hours trading after the company updated the progress of a clinical trial application for gout treatment submitted to Health Canada.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending